Diagnosis and treatment of cutaneous melanoma: state of the art 2006.
about
GPR56 Regulates VEGF production and angiogenesis during melanoma progressionAnatomical and molecular imaging of skin cancerNanotechnology for the treatment of melanoma skin cancer.PPARbeta activation inhibits melanoma cell proliferation involving repression of the Wilms' tumour suppressor WT1.Protein signatures for survival and recurrence in metastatic melanoma.Detection of melanoma nodal metastases; differences in detection between elderly and younger patients do not affect survival.Dacarbazine and the agonistic TRAIL receptor-2 antibody lexatumumab induce synergistic anticancer effects in melanoma.Preclinical investigation of tolerance and antitumour activity of new fluorodeoxyglucose-coupled chlorambucil alkylating agents.Circulating miR-221 expression level and prognosis of cutaneous malignant melanoma.Nanotechnology in dermatology.Systematic review of medical treatment in melanoma: current status and future prospects.Adjuvant therapy: melanomaAddressing the health benefits and risks, involving vitamin D or skin cancer, of increased sun exposureImmune toxicities and long remission duration after ipilimumab therapy for metastatic melanoma: two illustrative cases.A melanoma risk score in a Brazilian population.Retinoid and thiazolidinedione therapies in melanoma: an analysis of differential response based on nuclear hormone receptor expressionCurrent clinical overview of cutaneous melanoma.Combination PPARgamma and RXR Agonist Treatment in Melanoma Cells: Functional Importance of S100A2.Use of liposomes as drug delivery vehicles for treatment of melanoma.S-100B concentrations predict disease-free survival in stage III melanoma patients.A novel aliphatic 18F-labeled probe for PET imaging of melanoma.DR5 mAb-conjugated, DTIC-loaded immuno-nanoparticles effectively and specifically kill malignant melanoma cells in vivo.The case for early detection of melanoma.The glutamate release inhibitor Riluzole decreases migration, invasion, and proliferation of melanoma cellsmiRNAs and Melanoma: How Are They Connected?Peroxisome proliferator-activated receptors (PPARs) in dermatology: Challenge and promise.Immunotherapy for the management of advanced melanoma: the next steps.Immunotherapy of melanoma: efficacy and mode of action.Design and synthesis of a new series of highly potent RAF kinase-inhibiting triarylpyrazole derivatives possessing antiproliferative activity against melanoma cells.MicroRNAs role as potential biomarkers and key regulators in melanoma.Synthesis of quinolinylaminopyrimidines and quinazolinylmethylaminopyrimidines with antiproliferative activity against melanoma cell line.DC-81-enediyne induces apoptosis of human melanoma A375 cells: involvement of the ROS, p38 MAPK, and AP-1 signaling pathways.WT1 silencing by RNAi synergizes with chemotherapeutic agents and induces chemosensitization to doxorubicin and cisplatin in B16F10 murine melanoma cells.Design, synthesis, and antiproliferative activity of 3,4-diarylpyrazole-1-carboxamide derivatives against melanoma cell line.A label-free indicator for tumor cells based on the CH2-stretch ratio.Synthesis of 1H-pyrazole-1-carboxamide derivatives and their antiproliferative activity against melanoma cell line.Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanomaTargeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development.Synthesis and antiproliferative activity of imidazole and imidazoline analogs for melanoma.Awareness of sunburn in childhood, use of sunbeds and change of moles in Denmark, Northern Ireland, Norway and Sweden.
P2860
Q24309605-E2D0675F-72AD-49D4-83F4-5643856F471BQ30476227-8F68A048-FBDF-4555-AC1B-6D0A37C1EB03Q33694294-665C3E87-BAC5-411B-8532-741E323849EEQ33742630-32D7DB4E-F3B1-484B-85AB-5751D24DBE1CQ33891766-4F7414B5-817F-4FF8-96D1-145A0E6B7282Q34180205-73603961-7BE7-42F3-8612-823B14F6D65CQ34429203-DAED9C73-E65A-467F-9987-3DEFD30F931AQ34615208-76C19663-6B4C-42CC-85D6-C6D23DCBDC14Q34655391-FC52F821-2502-47F8-B955-E3CCA279AAD4Q35120307-2168B411-AC0B-4189-A17A-9635197617E0Q35584299-970029DA-C8CF-481B-8B99-0788511285F2Q35636225-76FC99E3-5186-4F3C-BF99-49EB26561457Q36392983-ABEDE151-6891-43C1-9733-742726D64880Q36738559-EF30699E-BA36-487F-8DAF-4C4B774DE875Q37114285-F768A06A-1D63-461B-AF46-64409178BA11Q37126227-3D287DE9-3974-4052-BE48-E209FFDA24A6Q37139142-5B4B989B-2876-49F6-ADBF-3F837668E3CBQ37390008-1B716E1D-8F98-4C43-9ECC-F75B5E84FB55Q37406217-8930D197-5F8B-4E3E-BB65-6820678E5B92Q37425922-A2903DAC-22A0-41F5-86D2-8603766997F1Q37624536-58F80692-9100-4CD2-BE94-E41CB1F76F7BQ37636774-BC0F57CF-8427-47F9-9D5B-39F5903C361FQ37686581-7708CBAC-EAEE-4732-B509-62FE70B21783Q37731451-35280DCC-71AF-4ED3-8FA4-A300815D065AQ37921096-7B08BAB3-9440-4F44-8DE1-158BFF928F2BQ37959975-EAE34CA1-7F63-4683-90ED-E80752B7B892Q38091675-4400D32C-9C30-480D-8136-44102299F0D1Q38682131-0BC562C2-57E5-47F2-B911-E7382DF007CBQ38731016-5685EBCB-B3D6-499E-B535-AC176F3064BEQ38937088-73451D4E-DB25-4269-A323-5246F7D82764Q38937232-50F80972-C323-4C11-B4D6-86B0EE931D5EQ39215755-BD2F66C2-C24F-43C5-AF1B-20043E45763BQ39323696-1C6937EB-989F-4BCE-B467-797BC4024038Q39466886-95781DDF-A51A-4DE3-91C6-019312178738Q39557286-A50A43FF-BF16-4365-99BE-483C8A179290Q39579562-9CC31CBF-356E-43B3-A483-ADC61178F5DFQ39874999-9044DC1C-6217-49E7-97C0-0518D852ADA0Q39899988-87241F49-52F4-4ED9-92BA-54C3F3BFAFA7Q39982741-13B8864E-2204-4ED1-9B8F-B6008B6CFD35Q41663450-D6730F79-7209-4E30-A6E2-5886315585B6
P2860
Diagnosis and treatment of cutaneous melanoma: state of the art 2006.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Diagnosis and treatment of cutaneous melanoma: state of the art 2006.
@ast
Diagnosis and treatment of cutaneous melanoma: state of the art 2006.
@en
type
label
Diagnosis and treatment of cutaneous melanoma: state of the art 2006.
@ast
Diagnosis and treatment of cutaneous melanoma: state of the art 2006.
@en
prefLabel
Diagnosis and treatment of cutaneous melanoma: state of the art 2006.
@ast
Diagnosis and treatment of cutaneous melanoma: state of the art 2006.
@en
P1433
P1476
Diagnosis and treatment of cutaneous melanoma: state of the art 2006
@en
P2093
Claus Garbe
Thomas K Eigentler
P304
P356
10.1097/CMR.0B013E328042BB36
P407
P577
2007-04-01T00:00:00Z